AstraZeneca unit AstraZeneca Finance admits EUR 2.55 billion bond offering to London Stock Exchange trading
AZN•Maturity schedule and amounts
The offering comprised Notes due 2030, 2032, 2035, and 2038, with aggregate nominal amounts ranging from EUR 500 million to EUR 750 million.
Bond offering admitted to trading
AstraZeneca Finance LLC launched a EUR 2.55 billion bond offering, with four debt securities admitted to trading on the LSE’s Main Market.
Admission to trading was effective Sept. 1, 2026.
